COMBIGAN Eye Drops 5ml is a prescription ophthalmic solution containing a combination of Brimonidine Tartrate 0.2% and Timolol 0.5%. It is specifically formulated to help reduce elevated intraocular pressure (IOP) in people with glaucoma or ocular hypertension when additional pressure control is required.
Combigan combines two medicines that lower pressure inside the eye through complementary mechanisms. Brimonidine is an alpha-adrenergic receptor agonist that reduces aqueous humour production and increases uveoscleral outflow, while Timolol is a beta-adrenergic receptor blocker that primarily reduces aqueous humour production. Together, these actions help lower elevated intraocular pressure.
The medicine is supplied as a sterile ophthalmic solution in a 5ml dropper bottle and is intended for topical use in the eye. Because Combigan contains timolol, a beta-blocker, it is important to use this medicine only according to the instructions of an ophthalmologist or other qualified healthcare professional.
| Product Information | Details |
|---|---|
| Brand Name | COMBIGAN |
| Dosage Form | Sterile ophthalmic solution / eye drops |
| Pack Size | 5ml |
| Active Ingredients | Brimonidine Tartrate + Timolol |
| Brimonidine Strength | 0.2% |
| Timolol Strength | 0.5% |
| Equivalent Concentration | Brimonidine Tartrate 2mg/ml + Timolol 5mg/ml |
| Drug Class | Antiglaucoma / IOP-lowering medicine |
| Main Use | Reduction of elevated intraocular pressure |
| Conditions | Glaucoma and ocular hypertension |
| Route | Ophthalmic / topical eye use |
| Prescription Status | Prescription medicine |
Official product information confirms that each ml contains 2mg brimonidine tartrate and timolol equivalent to 5mg timolol, supplied in a 5ml bottle.
COMBIGAN is designed to reduce intraocular pressure (IOP), which is an important part of managing glaucoma and ocular hypertension. Persistent elevation of pressure inside the eye can place stress on the optic nerve, so appropriate pressure control is an important part of glaucoma management.
Combigan contains two active ingredients:
The two medicines work through complementary mechanisms to provide pressure-lowering effects.
Combigan is indicated for reducing elevated IOP in patients with glaucoma when pressure is not adequately controlled with appropriate therapy.
COMBIGAN can also be used to reduce elevated intraocular pressure in people with ocular hypertension, according to the approved product information.
The 5ml sterile ophthalmic solution comes in a dropper bottle designed for topical administration to the affected eye or eyes.
COMBIGAN Eye Drops 5ml is used to reduce elevated intraocular pressure in conditions such as:
The official U.S. prescribing information states that Combigan is indicated for reducing elevated IOP in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy because their IOP is not adequately controlled.
Glaucoma can damage the optic nerve and may gradually affect vision. Lowering elevated intraocular pressure is one of the principal approaches used to reduce the risk of further glaucoma-related damage.
Important: Combigan controls elevated eye pressure; it does not reverse established optic-nerve damage. Regular ophthalmic examinations remain important for people with glaucoma.
Brimonidine is an alpha-2 adrenergic receptor agonist. It helps lower intraocular pressure by reducing aqueous humour formation and increasing uveoscleral outflow.
Brimonidine contributes to:
Timolol is a non-selective beta-adrenergic receptor blocker. In the eye, it lowers intraocular pressure primarily by reducing the production of aqueous humour.
Timolol contributes to:
The eye continuously produces a clear fluid called aqueous humour. This fluid normally circulates through the front portion of the eye and drains through natural outflow pathways.
When the balance between production and drainage is disrupted, pressure inside the eye may become elevated.
COMBIGAN combines two mechanisms:
Brimonidine → reduces aqueous humour production + increases uveoscleral outflow
Timolol → reduces aqueous humour production
Together, these effects reduce the amount of fluid contributing to intraocular pressure and therefore help lower elevated IOP.
The commonly recommended adult dose is:
One drop in the affected eye(s) twice daily, approximately 12 hours apart.
However, your ophthalmologist's prescribed dosage should always take priority.
Do not increase the number of drops or frequency of administration because you believe that more drops will lower eye pressure faster.
If you are using another topical ophthalmic medicine, the products should generally be administered at least 5 minutes apart.
Follow your ophthalmologist's instructions carefully.
Avoid squeezing the bottle excessively or administering additional drops unless instructed.
Do not allow the dropper tip to touch your:
Touching the tip can contaminate the sterile solution.
COMBIGAN should not be shared with another person, even if they have similar eye-pressure problems.
If prescribed twice daily, try to use the drops approximately 12 hours apart, as directed.
COMBIGAN contains benzalkonium chloride, a preservative that may be absorbed by soft contact lenses and can cause lens discoloration. Contact lenses should be removed before administration. The product information advises waiting at least 15 minutes after using Combigan before reinserting soft contact lenses.
Like all medicines, COMBIGAN may cause side effects.
Possible eye-related effects may include:
Because Combigan contains timolol, systemic beta-blocker-related effects can also occur in some patients.
Possible systemic effects can include:
Seek medical attention promptly if you experience difficulty breathing, severe dizziness, fainting, unusually slow heartbeat, severe allergic reaction, or significant changes in vision.
Tell your doctor before using COMBIGAN if you have:
The official prescribing information specifically lists bronchial asthma, a history of bronchial asthma, severe COPD, sinus bradycardia, certain heart conduction disorders, overt cardiac failure, cardiogenic shock, and hypersensitivity among contraindications.
Extra caution is required because COMBIGAN contains timolol, a beta-blocker.
Timolol can affect beta receptors outside the eye after systemic absorption and may cause bronchospasm in susceptible individuals.
COMBIGAN is contraindicated in patients with bronchial asthma, a history of bronchial asthma, and severe COPD according to the prescribing information.
If you have asthma or significant breathing disease, tell your ophthalmologist before using Combigan.
Because timolol is a beta-blocker, it can affect cardiovascular function.
Tell your doctor if you have:
COMBIGAN is contraindicated in certain significant cardiovascular conditions, including sinus bradycardia, second- or third-degree atrioventricular block, overt cardiac failure, and cardiogenic shock.
If you are pregnant, planning pregnancy, or think you may be pregnant, consult your ophthalmologist before using COMBIGAN.
Do not start, stop, or change glaucoma treatment during pregnancy without professional medical advice.
Your doctor will consider the importance of controlling eye pressure together with the potential risks and benefits of treatment.
Tell your doctor if you are breastfeeding.
Because COMBIGAN contains timolol and brimonidine, your healthcare professional should determine whether the medicine is appropriate during breastfeeding.
COMBIGAN is not intended to be used casually in children.
The product information states that Combigan is contraindicated in neonates and infants younger than 2 years. Pediatric use requires appropriate specialist medical assessment.
Do not administer Combigan to a child unless it has been specifically prescribed.
Tell your doctor about all medicines you take, including prescription medicines, over-the-counter medicines, eye drops, and supplements.
Particular attention may be needed with:
Because both active ingredients can have systemic effects, your ophthalmologist should know about your complete medication list.
Yes, a doctor may prescribe Combigan together with other ophthalmic medicines when additional pressure control is required.
However, different eye drops should generally be separated by at least 5 minutes to reduce the likelihood of one medication washing out the other.
Always follow the exact schedule provided by your ophthalmologist.
If you forget a dose, use it when you remember unless it is nearly time for your next scheduled dose.
If it is almost time for the next dose, skip the missed dose and continue with your regular schedule.
Do not use two doses at once to compensate for a missed dose.
If you frequently forget your eye drops, ask your ophthalmologist or pharmacist for strategies to help maintain your treatment schedule.
Using substantially more COMBIGAN than prescribed can increase exposure to brimonidine and timolol.
Accidental excessive use may potentially produce symptoms such as:
If you accidentally administer a large amount or swallow the contents, seek medical advice promptly.
Store COMBIGAN according to the storage instructions on the product packaging.
Official product information specifies storage below 25°C and protected from light for the referenced formulation. Keep the bottle tightly closed and avoid contaminating the dropper tip.
The product information states that the bottle should be discarded 4 weeks after opening, even if some solution remains.
Always follow the instructions on the specific pack you receive.
| Specification | Details |
|---|---|
| Product | COMBIGAN Eye Drops |
| Pack Size | 5ml |
| Form | Sterile ophthalmic solution |
| Brimonidine Tartrate | 0.2% |
| Timolol | 0.5% |
| Brimonidine Tartrate per ml | 2mg |
| Timolol per ml | 5mg |
| Preservative | Benzalkonium chloride |
| Drug Category | Antiglaucoma medicine |
| Main Action | Reduces elevated intraocular pressure |
| Main Conditions | Glaucoma and ocular hypertension |
| Route | Ophthalmic |
| Prescription | Yes |
The 0.2%/0.5% strength and 5ml presentation are confirmed by official product information.
COMBIGAN provides a dual-ingredient approach to elevated intraocular pressure, combining brimonidine and timolol in one ophthalmic solution.
Instead of using separate bottles for these two active ingredients, the combination provides both mechanisms in a single prescribed eye drop.
COMBIGAN is a prescription eye drop containing Brimonidine Tartrate 0.2% and Timolol 0.5%. It is used to reduce elevated intraocular pressure in glaucoma and ocular hypertension.
COMBIGAN contains the combination of Brimonidine Tartrate + Timolol.
It is used to lower elevated intraocular pressure in people with glaucoma or ocular hypertension when additional pressure control is required.
COMBIGAN contains:
Brimonidine Tartrate 0.2% + Timolol 0.5%.
The bottle contains 5ml of ophthalmic solution.
The standard adult recommended dose is one drop in the affected eye(s) twice daily, approximately 12 hours apart, unless your ophthalmologist gives you different instructions.
Yes. COMBIGAN is indicated for reducing elevated intraocular pressure in glaucoma.
Yes. It is used for ocular hypertension and elevated intraocular pressure.
COMBIGAN helps control elevated eye pressure. It does not cure glaucoma or restore optic-nerve damage that has already occurred. Continue regular ophthalmologist appointments and use your medicine exactly as prescribed.
It can be prescribed alongside other eye medicines when clinically appropriate. Different topical ophthalmic medicines should generally be separated by at least 5 minutes.
Remove soft contact lenses before applying the drops because the product contains benzalkonium chloride. Wait at least 15 minutes before putting soft contact lenses back in.
COMBIGAN may not be suitable for people with asthma. The product is contraindicated in patients with bronchial asthma or a history of bronchial asthma and in severe COPD.
Because it contains timolol, a beta-blocker, systemic cardiovascular effects including a slow heartbeat can occur. People with certain heart conditions should not use it unless specifically evaluated by their doctor.
The referenced product information states that the bottle should be discarded four weeks after opening.
Yes. Official product information identifies COMBIGAN as a prescription medicine.
Looking for COMBIGAN Eye Drops 5ml in Pakistan? COMBIGAN contains Brimonidine Tartrate 0.2% + Timolol 0.5% and is used under medical supervision to reduce elevated intraocular pressure associated with glaucoma and ocular hypertension.
When purchasing COMBIGAN online, check the:
Because COMBIGAN is a prescription eye medicine, it should be used according to the treatment plan provided by your ophthalmologist.
Order COMBIGAN Eye Drops 5ml from a trusted pharmacy in Pakistan and use it only as directed by your eye-care professional.
COMBIGAN contains Brimonidine Tartrate and Timolol, prescription medicines used to reduce elevated intraocular pressure. This product information is intended for educational and product-description purposes and does not replace an ophthalmologist's diagnosis or treatment plan.
Do not start, stop, increase, or decrease COMBIGAN without medical advice. If you experience severe eye pain, sudden vision changes, significant breathing difficulty, fainting, severe dizziness, or other serious symptoms, seek urgent medical attention.
